Kirby JS - Search Results

1

Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.

Kirby JS, Hereford B, Thorlacius L, Villumsen B, Ingram JR, Garg A, Butt M, Esmann S, King T, Tan J, Jemec GBE. Kirby JS, et al. Br J Dermatol. 2021 Apr;184(4):681-687. doi: 10.1111/bjd.19344. Epub 2020 Sep 3. Br J Dermatol. 2021. PMID: 32602129 Free PMC article.

2

Health care utilization patterns and costs for patients with hidradenitis suppurativa.

Kirby JS, Miller JJ, Adams DR, Leslie D. Kirby JS, et al. JAMA Dermatol. 2014 Sep;150(9):937-44. doi: 10.1001/jamadermatol.2014.691. JAMA Dermatol. 2014. PMID: 24908260

3

Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa.

Khalsa A, Liu G, Kirby JS. Khalsa A, et al. Among authors: kirby js. J Am Acad Dermatol. 2015 Oct;73(4):609-14. doi: 10.1016/j.jaad.2015.06.053. Epub 2015 Jul 16. J Am Acad Dermatol. 2015. PMID: 26190241

4

Qualitative study shows disease damage matters to patients with hidradenitis suppurativa.

Kirby JS. Kirby JS. J Am Acad Dermatol. 2016 Jun;74(6):1269-70. doi: 10.1016/j.jaad.2016.01.001. J Am Acad Dermatol. 2016. PMID: 27185436 Free PMC article. No abstract available.

5

Exploring Coping Strategies for Patients With Hidradenitis Suppurativa.

Kirby JS, Sisic M, Tan J. Kirby JS, et al. JAMA Dermatol. 2016 Oct 1;152(10):1166-1167. doi: 10.1001/jamadermatol.2016.1942. JAMA Dermatol. 2016. PMID: 27304616 Free PMC article. No abstract available.

6

Development of a Quality-of-Life Measure for Hidradenitis Suppurativa.

Sisic M, Kirby JS, Boyal S, Plant L, McLellan C, Tan J. Sisic M, et al. Among authors: kirby js. J Cutan Med Surg. 2017 Mar/Apr;21(2):152-155. doi: 10.1177/1203475416677721. Epub 2016 Nov 12. J Cutan Med Surg. 2017. PMID: 27837158 Free PMC article.

7

Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.

Berry K, Butt M, Kirby JS. Berry K, et al. Among authors: kirby js. JAMA Dermatol. 2017 May 1;153(5):421-426. doi: 10.1001/jamadermatol.2016.5245. JAMA Dermatol. 2017. PMID: 28114674 Free PMC article.

8

Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.

Thorlacius L, Ingram JR, Garg A, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Christensen R, Jemec GB. Thorlacius L, et al. Among authors: kirby js. BMJ Open. 2017 Feb 20;7(2):e014733. doi: 10.1136/bmjopen-2016-014733. BMJ Open. 2017. PMID: 28219961 Free PMC article.

9

Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States.

Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Garg A, et al. Among authors: kirby js. JAMA Dermatol. 2017 Aug 1;153(8):760-764. doi: 10.1001/jamadermatol.2017.0201. JAMA Dermatol. 2017. PMID: 28492923 Free PMC article.

10

Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.

Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernández-Peñas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens EP, Randell S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Thorlacius L, et al. Among authors: kirby js. Br J Dermatol. 2018 Mar;178(3):715-721. doi: 10.1111/bjd.16093. Epub 2018 Feb 1. Br J Dermatol. 2018. PMID: 29080368 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page